Back to mobile site

Goldman Sachs Reiterates Buy Rating on Amgen (AMGN)

January 15, 2025 5:05 AM EST Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $370.00 price target on Amgen (NASDAQ: AMGN)The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login